ClinicalTrials.Veeva

Menu

Advanced Platelet-rich Fibrin Combined With Open Debridement in Management of Suprabony Periodontal Defects

O

October University for Modern Sciences and Arts

Status and phase

Completed
Phase 4

Conditions

Periodontitis, Adult

Treatments

Biological: advanced PRF

Study type

Interventional

Funder types

Other

Identifiers

NCT05730153
OMD 3-22

Details and patient eligibility

About

in this clinical trial, patients with periodontal defects will be treated with advanced platelet-rich fibrin in conjunction with open debridement

Full description

two groups of patients with suprabony defects, one will be treated with advanced platelet-rich fibrin in conjunction with open debridement and the other will be treated with open debridement alone. subjects will be evaluated for evidence of bone formation after 6 months of therapy

Enrollment

30 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with periodontal suprabony defects.

Exclusion criteria

  • pregnant females.
  • smokers.
  • systemic disease that contraindicate surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

30 participants in 2 patient groups

group 1
Active Comparator group
Treatment:
Biological: advanced PRF
group 2
Sham Comparator group
Treatment:
Biological: advanced PRF

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems